Dr. Rajesh Dash, MD, PhD

Dr. Dash practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Dash's NPI, 1205051018, was assigned on April 16, 2007. Dr. Dash graduated from University Of Cincinnati College Of Medicine in 2002. Dr. Dash holds California license A90849.

Dr. Dash's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Dash's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Dash to 1 more hospital, named with a free account. Dr. Dash's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dash practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Dash's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Dash is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Dash's licenses on file in 2 states: California and North Carolina.

Dmand AI lists chronic hypertension, circulation problems, congestive heart failure, coronary artery disease, heart failure, heart valve disorders, high cholesterol and intermittent racing heartbeat (PSVT) among the conditions Dr. Dash treats.

CMS data shows 1,175 Medicare services from Dr. Dash across 12 procedure codes in 2024, for 936 Medicare patients. Medicare paid $48,885 for them.

CMS counts 936 Medicare patients who saw Dr. Dash in 2024. The largest group is 65 to 74, with 362 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dash's median patient age at 57, with 41% women.

In 2024, Dr. Dash wrote 474 Medicare Part D claims for 58 patients. 89% of them were for generic drugs. CMS names the drug for 344 of them, across 14 drugs with 11 or more claims each, at $23,229 in total drug cost. In 2023, CMS named 273 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Dash for performance year 2024, reported as part of a group. Dr. Dash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dash as offering telehealth.

Dmand AI links 40 papers to Dr. Dash, published from 2011 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Magnetic Resonance Imaging, Myocardium and Contrast Media. Dr. Dash has published most often in J Telemed Telecare. Dr. Dash's most frequent co-authors are Phillip Chung-Ming Yang, MD, Fatima Rodriguez, MD and Michael Vincent C McConnell, MD.

CMS Open Payments shows 51 general payments to Dr. Dash from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 44% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,700. It also lists 1 research payment totaling $42 in 2025.

Dmand AI lists 1 award for Dr. Dash, most recently CMS Stage 1 EHR in 2013.

Dr. Dash graduated from University Of Cincinnati College Of Medicine in 2002. Dr. Dash is a member of ACC.

Dr. Dash is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.